Alkermes (ALKS) EBT Margin (2010 - 2026)
Alkermes' (ALKS) quarterly EBT Margin came in at 0.38% in Q2 2026, down 2721.0% year-over-year from 0.01% in Q2 2025, and up 97.6% quarter-over-quarter from 15.76% in Q1 2026.
Analysis
Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported EBT Margin for 17 consecutive years, with 0.38% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin fell 2721.0% year-over-year to 0.38% in Q2 2026; TTM through Jun 2026 was 5.84%, a 2143.0% decrease from a year earlier, with the FY2025 full-year figure at 19.75%, down 874.0% from the prior year.
- EBT Margin was 0.38% for Q2 2026 at Alkermes, up from 15.76% in the prior quarter.
- Over five years, EBT Margin peaked at 45.65% in Q2 2023 and troughed at 26.7% in Q3 2022.
- A 5-year average of 13.1% and a median of 15.57% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 5769 bps in 2023 and tumbled 2721 bps in 2026, its largest moves.
- Over 5 years, EBT Margin stood at 37.58% in 2022, then sank by 59 bps to 15.45% in 2023, then surged by 156 bps to 39.51% in 2024, then sank by 60 bps to 15.7% in 2025, then sank by 102 bps to 0.38% in 2026.
- The last three EBT Margin figures came in at 0.38% (Q2 2026), 15.76% (Q1 2026), and 15.7% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 29.63% |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn | -4.34% |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn | 12.17% |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - | - |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn | 44.89% |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn | 47.58% |
| 10 | Alkermes | 7.58 Bn | 6.93 Bn | 397.90 Mn | -0.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.38% |
| Mar 31, 2026 | -15.76% |
| Dec 31, 2025 | 15.70% |
| Sep 30, 2025 | 25.56% |
| Jun 30, 2025 | 26.84% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 39.51% |
| Sep 30, 2024 | 29.15% |
| Jun 30, 2024 | 29.24% |
| Mar 31, 2024 | 13.39% |
| Dec 31, 2023 | 15.45% |
| Sep 30, 2023 | 24.34% |
| Jun 30, 2023 | 45.65% |
| Mar 31, 2023 | -3.94% |
| Dec 31, 2022 | 37.58% |
| Sep 30, 2022 | -26.70% |
| Jun 30, 2022 | -12.04% |
| Mar 31, 2022 | -16.15% |
| Dec 31, 2021 | 39.22% |
| Sep 30, 2021 | -9.02% |